Acute Levetiracetam-Induced Thrombocytopenia in an Anticoagulated Immunocompetent Patient

Levetiracetam (LEV) is a commonly prescribed anti-seizure medication for the prophylaxis and treatment of focal and generalized seizures. However, a few significant LEV-associated adverse effects have been reported in the literature. Here, we describe a case of significant thrombocytopenia within 24...

Descripción completa

Detalles Bibliográficos
Autores principales: Nwaedozie, Somto T, Aatrai, Sheetal, Najjar Mojarrab, Javad, Al Twal, Abdullah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035701/
https://www.ncbi.nlm.nih.gov/pubmed/33850675
http://dx.doi.org/10.7759/cureus.13817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035701/
https://www.ncbi.nlm.nih.gov/pubmed/33850675
http://dx.doi.org/10.7759/cureus.13817

Ejemplares similares